Dr. Price attended the University of Michigan, where he received a B.S. with highest honors in psychology and high distinction in 1974, followed by an M.D. in 1978. After an internship in internal medicine at Norwalk Hospital, he completed a residency and fellowship in psychiatry at Yale University. From 1982 until 1996, Dr. Price was on the faculty in the Department of Psychiatry at Yale University, where he served as Associate Professor and Director of the Clinical Neuroscience Research Unit at the Connecticut Mental Health Center. Since 1996, he has been Professor of Psychiatry at Brown University. From 1996 to 2012, he was Clinical Director, Director of Research, and Chair of the Institutional Review Board at Butler Hospital in Providence, Rhode Island, subsequently serving as Chief Medical Officer from 2012 until 2014. He is currently President of Butler Hospital and Executive Chief of the Brain and Behavioral Health Service Line of Care New England. He was identified by the Institute for Scientific Information as one of the top ten authors of high-impact papers in psychiatry from 1990 to 1999. In addition to his research activities, Dr. Price has received numerous awards for his teaching and clinical work, and is Editor of the Brown University Psychopharmacology Update and Editor (with I. Stolerman) of the Encyclopedia of Psychopharmacology, Second Edition.
| Laferton JAC, Vijapura S, Baer L, Clain AJ, Cooper A, Papakostas G, Price LH, Carpenter LL, Tyrka AR, Fava M, Mischoulon D. "Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression." Frontiers in Psychiatry, vol. 9, 2018, pp. 424. |
| Minami H, Brinkman HR, Nahvi S, Arnsten JH, Rivera-Mindt M, Wetter DW, Bloom EL, Price LH, Vieira C, Donnelly R, McClain LM, Kennedy KA, D'Aquila E, Fine M, McCarthy DE, Graham Thomas J, Hecht J, Brown RA. "Rationale, design and pilot feasibility results of a smartphone-assisted, mindfulness-based intervention for smokers with mood disorders: Project mSMART MIND." Contemporary Clinical Trials, vol. 66, 2018, pp. 36-44. |
| Brown RA, Hecht J, Bloom EL, Minami H, Kahler CW, Abrantes AM, Dubreuil ME, Gordon A, Price LH, Ondersma SJ. "Development and preliminary pilot evaluation of a brief tablet computer intervention to motivate tobacco quitline use among smokers in substance use treatment." The American Journal on Addictions, vol. 26, no. 6, 2017, pp. 587-594. |
| Tyrka, Audrey R., Parade, Stephanie H., Price, Lawrence H., Kao, Hung-Teh, Porton, Barbara, Philip, Noah S., Welch, Emma S., Carpenter, Linda L. "Alterations of Mitochondrial DNA Copy Number and Telomere Length With Early Adversity and Psychopathology." Biological Psychiatry, vol. 79, no. 2, 2016, pp. 78-86. |
| Tyrka, Audrey R., Parade, Stephanie H., Price, Lawrence H., Kao, Hung-Teh, Porton, Barbara, Philip, Noah S., Welch, Emma S., Carpenter, Linda L. "Alterations of Mitochondrial DNA Copy Number and Telomere Length With Early Adversity and Psychopathology." Biological Psychiatry, vol. 79, no. 2, 2016, pp. 78-86. |
| Ridout KK, Ridout SJ, Price LH, Sen S, Tyrka AR. "Depression and telomere length: A meta-analysis." Journal of affective disorders, vol. 191, 2016, pp. 237-47. |
| Bloom, Erika Litvin, Wing, Rena R., Kahler, Christopher W., Thompson, J. Kevin, Meltzer, Sari, Hecht, Jacki, Minami, Haruka, Price, Lawrence H., Brown, Richard A. "Distress Tolerance Treatment for Weight Concern in Smoking Cessation Among Women: The WE QUIT Pilot Study." Behavior Modification, vol. 41, no. 4, 2016, pp. 468-498. |
| Steckler, Thomas, Curran, H. Valerie, de Wit, Harriet, Howes, Oliver, Hoyer, Daniel, Lucki, Irwin, Miczek, Klaus A., Morrow, A. Leslie, Price, Lawrence H., Robbins, Trevor W. "Editorial: Reporting guidelines for psychopharmacology." Psychopharmacology, vol. 233, no. 7, 2016, pp. 1131-1134. |
| Steckler T, Curran HV, de Wit H, Howes O, Hoyer D, Lucki I, Miczek KA, Morrow AL, Price LH, Robbins TW. "Editorial: Reporting guidelines for psychopharmacology." Psychopharmacology, vol. 233, no. 7, 2016, pp. 1131-4. |
| Tyrka AR, Parade SH, Welch ES, Ridout KK, Price LH, Marsit C, Philip NS, Carpenter LL. "Methylation of the leukocyte glucocorticoid receptor gene promoter in adults: associations with early adversity and depressive, anxiety and substance-use disorders." Translational psychiatry, vol. 6, no. 7, 2016, pp. e848. |
| Philip, Noah S., Carpenter, S. Louisa, Ridout, Samuel J., Sanchez, George, Albright, Sarah E., Tyrka, Audrey R., Price, Lawrence H., Carpenter, Linda L. "5Hz Repetitive transcranial magnetic stimulation to left prefrontal cortex for major depression." Journal of affective disorders, vol. 186, 2015, pp. 13-7. |
| Dougherty DD, Rezai AR, Carpenter LL, Howland RH, Bhati MT, O'Reardon JP, Eskandar EN, Baltuch GH, Machado AD, Kondziolka D, Cusin C, Evans KC, Price LH, Jacobs K, Pandya M, Denko T, Tyrka AR, Brelje T, Deckersbach T, Kubu C, Malone DA Jr. "A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression." Biological Psychiatry, vol. 78, no. 4, 2015, pp. 240-248. |
| Tyrka, Audrey R., Carpenter, Linda L., Kao, Hung-Teh, Porton, Barbara, Philip, Noah S., Ridout, Samuel J., Ridout, Kathryn K., Price, Lawrence H. "Association of telomere length and mitochondrial DNA copy number in a community sample of healthy adults." Experimental Gerontology, vol. 66, 2015, pp. 17-20. |
| Minami, Haruka, Kahler, Christopher W., Bloom, Erika L., Strong, David R., Abrantes, Ana M., Zywiak, William H., Price, Lawrence H., Brown, Richard A. "Effects of Depression History and Sex on the Efficacy of Sequential Versus Standard Fluoxetine for Smoking Cessation in Elevated Depressive Symptom Smokers." Addictive Disorders & Their Treatment, vol. 14, no. 1, 2015, pp. 29-39. |
| Philip, Noah S., Sweet, Lawrence H., Tyrka, Audrey R., Carpenter, S. Louisa, Albright, Sarah E., Price, Lawrence H., Carpenter, Linda L. "Exposure to childhood trauma is associated with altered n-back activation and performance in healthy adults: implications for a commonly used working memory task." Brain Imaging and Behavior, vol. 10, no. 1, 2015, pp. 124-35. |
| Sarris J, Price LH, Carpenter LL, Tyrka AR, Ng CH, Papakostas GI, Jaeger A, Fava M, Mischoulon D. "Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial." Pharmacopsychiatry, vol. 48, no. 4-5, 2015, pp. 141-144. |
| Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Baer L, Dording CM, Clain AJ, Durham K, Walker R, Ludington E, Fava M. "A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder." J. Clin. Psychiatry, vol. 75, no. 4, 2014, pp. 370-6. |
| Hantsoo L, Ward-O'Brien D, Czarkowski KA, Gueorguieva R, Price LH, Epperson CN. "A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression." Psychopharmacology, vol. 231, no. 5, 2014, pp. 939-48. |
| Mischoulon, David, Price, Lawrence H., Carpenter, Linda L., Tyrka, Audrey R., Papakostas, George I., Fava, Maurizio. "Dr Mischoulon and Colleagues Reply." J. Clin. Psychiatry, 2014, pp. e1329-e1329. |
| Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Fava M. "Dr. Mischoulon and colleagues reply." J. Clin. Psychiatry, vol. 75, no. 11, 2014, pp. e1328-9. |
| Philip NS, Valentine TR, Sweet LH, Tyrka AR, Price LH, Carpenter LL. "Early life stress impacts dorsolateral prefrontal cortex functional connectivity in healthy adults: informing future studies of antidepressant treatments." Journal of Psychiatric Research, vol. 52, 2014, pp. 63-9. |
| Minami H, Kahler CW, Bloom EL, Prince MA, Abrantes AM, Strong DR, Niaura R, Miller IW, Palm Reed KM, Price LH, Brown RA. "Effects of sequential fluoxetine and gender on prequit depressive symptoms, affect, craving, and quit day abstinence in smokers with elevated depressive symptoms: a growth curve modeling approach." Experimental and Clinical Psychopharmacology, vol. 22, no. 5, 2014, pp. 392-406. |
| Brown RA, Abrantes AM, Strong DR, Niaura R, Kahler CW, Miller IW, Price LH. "Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers." Nicotine & Tobacco Research, vol. 16, no. 2, 2014, pp. 197-207. |
| Ridout KK, Parade SH, Seifer R, Price LH, Gelernter J, Feliz P, Tyrka AR. "Interleukin 1B gene (IL1B) variation and internalizing symptoms in maltreated preschoolers." Dev Psychopathol, vol. 26, no. 4 Pt 2, 2014, pp. 1277-87. |
| Tuya Fulton A, Sullivan JK, Price LH. "Concurrent care at an academic psychiatric hospital." PS, vol. 64, no. 3, 2013, pp. 290. |
| Case BG, Bertollo DN, Laska EM, Price LH, Siegel CE, Olfson M, Marcus SC. "Declining use of electroconvulsive therapy in U.S. general hospitals is not restricted to unipolar depression." Biological Psychiatry, vol. 74, no. 10, 2013, pp. e19-20. |
| Case BG, Bertollo DN, Laska EM, Price LH, Siegel CE, Olfson M, Marcus SC. "Declining use of electroconvulsive therapy in United States general hospitals." Biological Psychiatry, vol. 73, no. 2, 2013, pp. 119-26. |
| Philip NS, Sweet LH, Tyrka AR, Price LH, Bloom RF, Carpenter LL. "Decreased default network connectivity is associated with early life stress in medication-free healthy adults." European Neuropsychopharmacology, vol. 23, no. 1, 2013, pp. 24-32. |
| Hitsman B, Hogarth L, Tseng LJ, Teige JC, Shadel WG, DiBenedetti DB, Danto S, Lee TC, Price LH, Niaura R. "Dissociable effect of acute varenicline on tonic versus cue-provoked craving in non-treatment-motivated heavy smokers." Drug and Alcohol Dependence, vol. 130, no. 1-3, 2013, pp. 135-41. |
| Philip NS, Sweet LH, Tyrka AR, Price LH, Carpenter LL, Kuras YI, Clark US, Niaura RS. "Early life stress is associated with greater default network deactivation during working memory in healthy controls: a preliminary report." Brain Imaging and Behavior, vol. 7, no. 2, 2013, pp. 204-12. |
| Philip NS, Kuras YI, Valentine TR, Sweet LH, Tyrka AR, Price LH, Carpenter LL. "Regional homogeneity and resting state functional connectivity: associations with exposure to early life stress." Psychiatry Research, vol. 214, no. 3, 2013, pp. 247-53. |
| Price LH, Kao HT, Burgers DE, Carpenter LL, Tyrka AR. "Telomeres and early-life stress: an overview." Biological Psychiatry, vol. 73, no. 1, 2013, pp. 15-23. |
| Tyrka AR, Burgers DE, Philip NS, Price LH, Carpenter LL. "The neurobiological correlates of childhood adversity and implications for treatment." Acta psychiatrica Scandinavica, vol. 128, no. 6, 2013, pp. 434-47. |
| Ton, Hendry, Xiong, Glen, Hilty, Donald, Price, Lawrence, Brescia, Robert, Méndez, Lina, Patron, David. "The Psychiatric Interview: A Self-Directed Learning Module." MedEdPORTAL Publications, 2013. |
| Gawuga, C.E., Tyrka, A.R., Price, L.H., Carpenter, L.L. "145. Temporal associations between IL-6 and cortisol production in response to acute psychosocial stress." Brain, Behavior, and Immunity, vol. 26, 2012, pp. S40. |
| Tyrka AR, Walters OC, Price LH, Anderson GM, Carpenter LL. "Altered response to neuroendocrine challenge linked to indices of the metabolic syndrome in healthy adults." Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, vol. 44, no. 7, 2012, pp. 543-9. |
| Carpenter LL, Gawuga CE, Tyrka AR, Price LH. "C-reactive protein, early life stress, and wellbeing in healthy adults." Acta psychiatrica Scandinavica, vol. 126, no. 6, 2012, pp. 402-10. |
| Tyrka AR, Price LH, Marsit C, Walters OC, Carpenter LL. "Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults." PLoS ONE, vol. 7, no. 1, 2012, pp. e30148. |
| Philip NS, Carpenter LL, Tyrka AR, Price LH. "The nicotinic acetylcholine receptor as a target for antidepressant drug development." TheScientificWorldJournal, vol. 2012, 2012, pp. 104105. |
| McGuire JF, Storch EA, Lewin AB, Price LH, Rasmussen SA, Goodman WK. "The role of avoidance in the phenomenology of obsessive-compulsive disorder." Comprehensive Psychiatry, vol. 53, no. 2, 2012, pp. 187-94. |
| Carpenter LL, Tyrka AR, Lee JK, Tracy AP, Wilkinson CW, Price LH. "A placebo-controlled study of sertraline's effect on cortisol response to the dexamethasone/corticotropin-releasing hormone test in healthy adults." Psychopharmacology, vol. 218, no. 2, 2011, pp. 371-9. |
| Price LH, Steckler T. "Early life stress and psychopharmacology." Psychopharmacology, vol. 214, no. 1, 2011, pp. 1-3. |
| Carpenter LL, Shattuck TT, Tyrka AR, Geracioti TD, Price LH. "Effect of childhood physical abuse on cortisol stress response." Psychopharmacology, vol. 214, no. 1, 2011, pp. 367-75. |
| Nugent NR, Tyrka AR, Carpenter LL, Price LH. "Gene-environment interactions: early life stress and risk for depressive and anxiety disorders." Psychopharmacology, vol. 214, no. 1, 2011, pp. 175-96. |
| Nierenberg AA, Leon A, Price LH, Shelton RC, Trivedi MH. "The current crisis of confidence in antidepressants." J. Clin. Psychiatry, vol. 72, no. 1, 2011, pp. 27-33. |
| Cui D, Zhang H, Yang BZ, Listman JB, Li D, Price LH, Carpenter LL, Tyrka AR, Anton RF, Kranzler HR, Gelernter J. "Variation in NGFB is associated with primary affective disorders in women." Am. J. Med. Genet., vol. 156B, no. 4, 2011, pp. 401-12. |
| Amin Z, Kanarek K, Krupitsky E, Walderhaug E, Ilomäki R, Blumberg H, Price LH, Bhagwagar Z, Carpenter LL, Tyrka AR, Magnusson A, Landrø NI, Zvartau E, Gelernter J, Epperson CN, Räsänen P, Siironen J, Lappalainen J. "A sequencing-based survey of functional APAF1 alleles in a large sample of individuals with affective illness and population controls." Am. J. Med. Genet., vol. 153B, no. 1, 2010, pp. 332-5. |
| Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH. "Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults." Neuropsychopharmacology, vol. 35, no. 13, 2010, pp. 2617-23. |
| Tyrka AR, Price LH, Kao HT, Porton B, Marsella SA, Carpenter LL. "Childhood maltreatment and telomere shortening: preliminary support for an effect of early stress on cellular aging." Biological Psychiatry, vol. 67, no. 6, 2010, pp. 531-4. |
| Storch EA, Rasmussen SA, Price LH, Larson MJ, Murphy TK, Goodman WK. "Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition." Psychological Assessment, vol. 22, no. 2, 2010, pp. 223-32. |
| Tyrka AR, Price LH, Carpenter LL, Anderson GM. "In Reply to: Childhood Maltreatment and Hypothalamic-Pituitary-Adrenal Axis Reactivity." Biological Psychiatry, vol. 67, no. 11, 2010, pp. e61-2. |
| Tyrka, Audrey R., Price, Lawrence H., Kao, Hung-Teh, Porton, Barbara, Carpenter, Linda L. "In Response to “No Correlation Between Childhood Maltreatment and Telomere Length”." Biological Psychiatry, vol. 68, no. 6, 2010, pp. e23-e24. |
| Hitsman B, Shen BJ, Cohen RA, Morissette SB, Drobes DJ, Spring B, Schneider K, Evans DE, Gulliver SB, Kamholz BW, Price LH, Niaura R. "Measuring smoking-related preoccupation and compulsive drive: evaluation of the obsessive compulsive smoking scale." Psychopharmacology, vol. 211, no. 4, 2010, pp. 377-87. |
| Philip NS, Carpenter LL, Tyrka AR, Price LH. "Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature." Psychopharmacology, vol. 212, no. 1, 2010, pp. 1-12. |
| Philip NS, Carpenter LL, Tyrka AR, Price LH. "Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era." Expert opinion on pharmacotherapy, vol. 11, no. 5, 2010, pp. 709-22. |
| Storch EA, Larson MJ, Price LH, Rasmussen SA, Murphy TK, Goodman WK. "Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist." Journal of Anxiety Disorders, vol. 24, no. 6, 2010, pp. 650-6. |
| Schoedl AF, Costa MC, Mari JJ, Mello MF, Tyrka AR, Carpenter LL, Price LH. "The clinical correlates of reported childhood sexual abuse: an association between age at trauma onset and severity of depression and PTSD in adults." Journal of child sexual abuse, vol. 19, no. 2, 2010, pp. 156-70. |
| Mello MF, Faria AA, Mello AF, Carpenter LL, Tyrka AR, Price LH. "[Childhood maltreatment and adult psychopathology: pathways to hypothalamic-pituitary-adrenal axis dysfunction]." Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), vol. 31 Suppl 2, 2009, pp. S41-8. |
| Brown RA, Lejuez CW, Strong DR, Kahler CW, Zvolensky MJ, Carpenter LL, Niaura R, Price LH. "A prospective examination of distress tolerance and early smoking lapse in adult self-quitters." Nicotine & Tobacco Research, vol. 11, no. 5, 2009, pp. 493-502. |
| Price LH. "Atypical antipsychotic drugs and the risk of sudden cardiac death." New England Journal of Medicine, vol. 360, no. 20, 2009, pp. 2137; author reply 2137-8. |
| Tyrka AR, Wyche MC, Kelly MM, Price LH, Carpenter LL. "Childhood maltreatment and adult personality disorder symptoms: influence of maltreatment type." Psychiatry Research, vol. 165, no. 3, 2009, pp. 281-7. |
| Malone, Donald A., Dougherty, Darin D., Rezai, Ali R., Carpenter, Linda L., Friehs, Gerhard M., Eskandar, Emad N., Rauch, Scott L., Rasmussen, Steven A., Machado, Andre G., Kubu, Cynthia S., Tyrka, Audrey R., Price, Lawrence H., Stypulkowski, Paul H., Giftakis, Jonathon E., Rise, Mark T., Malloy, Paul F., Salloway, Stephen P., Greenberg, Benjamin D. "Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression." Biological Psychiatry, vol. 65, no. 4, 2009, pp. 267-275. |
| Carpenter LL, Ross NS, Tyrka AR, Anderson GM, Kelly M, Price LH. "Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls." Psychoneuroendocrinology, vol. 34, no. 8, 2009, pp. 1208-13. |
| Carpenter LL, Tyrka AR, Ross NS, Khoury L, Anderson GM, Price LH. "Effect of childhood emotional abuse and age on cortisol responsivity in adulthood." Biological Psychiatry, vol. 66, no. 1, 2009, pp. 69-75. |
| Tyrka AR, Price LH, Gelernter J, Schepker C, Anderson GM, Carpenter LL. "Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity." Biological Psychiatry, vol. 66, no. 7, 2009, pp. 681-5. |
| Mello, Marcelo F., Faria, Alvaro A., Mello, Andrea F., Carpenter, Linda L., Tyrka, Audrey R., Price, Lawrence H. "Maus-tratos na infância e psicopatologia no adulto: caminhos para a disfunção do eixo hipotálamo-pituitária-adrenal." Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), vol. 31, 2009. |
| Zuo L, Luo X, Listman JB, Kranzler HR, Wang S, Anton RF, Blumberg HP, Stein MB, Pearlson GD, Covault J, Charney DS, van Kammen DP, Price LH, Lappalainen J, Cramer J, Krystal JH, Gelernter J. "Population admixture modulates risk for alcohol dependence." Human Genetics, vol. 125, no. 5-6, 2009, pp. 605-13. |
| Philip, Noah S., Carpenter, Linda L., Tyrka, Audrey R., Whiteley, Laura B., Price, Lawrence H. "Varenicline augmentation in depressed smokers: an 8-week, open-label study." J. Clin. Psychiatry, vol. 70, no. 7, 2009, pp. 1026-1031. |
| Philip NS, Carpenter LL, Tyrka AR, Price LH. "Augmentation of antidepressants with atypical antipsychotics: a review of the current literature." Journal of Psychiatric Practice, vol. 14, no. 1, 2008, pp. 34-44. |
| Tyrka AR, Wier L, Price LH, Ross N, Anderson GM, Wilkinson CW, Carpenter LL. "Childhood parental loss and adult hypothalamic-pituitary-adrenal function." Biological Psychiatry, vol. 63, no. 12, 2008, pp. 1147-54. |
| Tyrka AR, Wier L, Price LH, Ross NS, Carpenter LL. "Childhood parental loss and adult psychopathology: effects of loss characteristics and contextual factors." International journal of psychiatry in medicine, vol. 38, no. 3, 2008, pp. 329-344. |
| Tyrka AR, Wier LM, Price LH, Rikhye K, Ross NS, Anderson GM, Wilkinson CW, Carpenter LL. "Cortisol and ACTH responses to the Dex/CRH test: influence of temperament." Hormones and behavior, vol. 53, no. 4, 2008, pp. 518-25. |
| Carpenter LL, Bayat L, Moreno F, Kling MA, Price LH, Tyrka AR, Kinkead B, Owens MJ, Nemeroff CB. "Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy." Psychiatry Research, vol. 157, no. 1-3, 2008, pp. 123-9. |
| Rikhye K, Tyrka AR, Kelly MM, Gagne GG Jr, Mello AF, Mello MF, Price LH, Carpenter LL. "Interplay between childhood maltreatment, parental bonding, and gender effects: impact on quality of life." Child Abuse & Neglect, vol. 32, no. 1, 2008, pp. 19-34. |
| Philip NS, Mello K, Carpenter LL, Tyrka AR, Price LH. "Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use." Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, vol. 20, no. 1, 2008, pp. 15-20. |
| Hitsman, B., Price, L.H. "S.23.05 Neurotransmitter challenges in nicotine addiction." European Neuropsychopharmacology, vol. 18, 2008, pp. S190. |
| Kelly MM, Tyrka AR, Anderson GM, Price LH, Carpenter LL. "Sex differences in emotional and physiological responses to the Trier Social Stress Test." Journal of Behavior Therapy and Experimental Psychiatry, vol. 39, no. 1, 2008, pp. 87-98. |
| Kelly MM, Tyrka AR, Price LH, Carpenter LL. "Sex differences in the use of coping strategies: predictors of anxiety and depressive symptoms." Depression and Anxiety, vol. 25, no. 10, 2008, pp. 839-46. |
| Abrantes AM, Strong DR, Lejuez CW, Kahler CW, Carpenter LL, Price LH, Niaura R, Brown RA. "The role of negative affect in risk for early lapse among low distress tolerance smokers." Addictive Behaviors, vol. 33, no. 11, 2008, pp. 1394-401. |
| Mello AF, Juruena MF, Pariante CM, Tyrka AR, Price LH, Carpenter LL, Del Porto JA. "[Depression and stress: is there an endophenotype?]." Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), vol. 29 Suppl 1, 2007, pp. S13-8. |
| Price LH, Tyrka AR. "Adjunctive antidepressant treatment for bipolar depression." New England Journal of Medicine, vol. 357, no. 6, 2007, pp. 614; author reply 615-6. |
| Carpenter LL, Carvalho JP, Tyrka AR, Wier LM, Mello AF, Mello MF, Anderson GM, Wilkinson CW, Price LH. "Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment." Biological Psychiatry, vol. 62, no. 10, 2007, pp. 1080-7. |
| Mello, Andrea Feijo, Juruena, Mario Francisco, Pariante, Carmine M, Tyrka, Audrey R, Price, Lawrence H, Carpenter, Linda L, Del Porto, Jose Alberto. "Depressão e estresse: existe um endofenótipo?." Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), vol. 29, 2007, pp. s13-s18. |
| Tyrka AR, Wier LM, Anderson GM, Wilkinson CW, Price LH, Carpenter LL. "Temperament and response to the Trier Social Stress Test." Acta psychiatrica Scandinavica, vol. 115, no. 5, 2007, pp. 395-402. |
| Grover KE, Carpenter LL, Price LH, Gagne GG, Mello AF, Mello MF, Tyrka AR. "The relationship between childhood abuse and adult personality disorder symptoms." Journal of personality disorders, vol. 21, no. 4, 2007, pp. 442-7. |
| Park MC, Goldman MA, Carpenter LL, Price LH, Friehs GM. "Vagus nerve stimulation for depression: rationale, anatomical and physiological basis of efficacy and future prospects." Acta Neurochirurgica Supplementum, vol. 97, no. Pt 2, 2007, pp. 407-16. |
| Tyrka AR, Carpenter LL, Carvalho JP, Price LH. "Biomarkers in the human stress system: do they signal risk for depression?." Medicine and health, Rhode Island, vol. 89, no. 5, 2006, pp. 180-2. |
| Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS, Price LH, Southwick S, Yang BZ, Rasmussen A, Gelernter J. "Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence." Am. J. Med. Genet., vol. 141B, no. 4, 2006, pp. 387-93. |
| Geracioti, Thomas D., Carpenter, Linda L., Owens, Michael J., Baker, Dewleen G., Ekhator, Nosakhare N., Horn, Paul S., Strawn, Jeffrey R., Sanacora, Gerard, Kinkead, Becky, Price, Lawrence H., Nemeroff, Charles B. "Elevated Cerebrospinal Fluid Substance P Concentrations in Posttraumatic Stress Disorder and Major Depression." American Journal of Psychiatry, vol. 163, no. 4, 2006, pp. 637-643. |
| Wier, Lauren M., Tavares, Sandra B., Tyrka, Audrey R., Price, Lawrence H., Carpenter, Linda L. "Levetiracetam-Induced Depression in a Healthy Adult." J. Clin. Psychiatry, vol. 67, no. 07, 2006, pp. 1156. |
| Wier LM, Tavares SB, Tyrka AR, Price LH, Carpenter LL. "Levetiracetam-induced depression in a healthy adult." J. Clin. Psychiatry, vol. 67, no. 7, 2006, pp. 1159-60. |
| Carpenter LL, Schecter JM, Tyrka AR, Mello AF, Mello MF, Haggarty R, Price LH. "Open-Label Tiagabine Monotherapy for Major Depressive Disorder With Anxiety." J. Clin. Psychiatry, vol. 67, no. 01, 2006, pp. 66-71. |
| Tyrka, Audrey R, Price, Lawrence H, Mello, Marcelo F, Mello, Andrea F, Carpenter, Linda L. "Psychotic major depression: a benefit-risk assessment of treatment options." Drug safety : an international journal of medical toxicology and drug experience, vol. 29, no. 6, 2006, pp. 491-508. |
| Tyrka AR, Mello AF, Mello MF, Gagne GG, Grover KE, Anderson GM, Price LH, Carpenter LL. "Temperament and hypothalamic-pituitary-adrenal axis function in healthy adults." Psychoneuroendocrinology, vol. 31, no. 9, 2006, pp. 1036-45. |
| Carpenter LL, Friehs GM, Tyrka AR, Rasmussen S, Price LH, Greenberg BD. "Vagus nerve stimulation and deep brain stimulation for treatment resistant depression." Medicine and health, Rhode Island, vol. 89, no. 4, 2006, pp. 137, 140-1. |
| Phillips KA, Grant JE, Siniscalchi JM, Stout R, Price LH. "A retrospective follow-up study of body dysmorphic disorder." Comprehensive Psychiatry, vol. 46, no. 5, 2005, pp. 315-21. |
| Carpenter LL, Milosavljevic N, Schecter JM, Tyrka AR, Price LH. "Augmentation With Open-Label Atomoxetine for Partial or Nonresponse to Antidepressants." J. Clin. Psychiatry, vol. 66, no. 10, 2005, pp. 1234-1238. |
| Carpenter LL, Schecter JM, Underwood JA, Tyrka AR, Price LH. "Service expectations and clinical characteristics of patients receiving psychiatric emergency services." PS, vol. 56, no. 6, 2005, pp. 743-5. |
| Carpenter LL, Schecter JM, Sinischalchi J, Leon Z, Price LH. "A case series describing orlistat use in patients on psychotropic medications." Medicine and health, Rhode Island, vol. 87, no. 12, 2004, pp. 375-7. |
| Carpenter LL, Tyrka AR, McDougle CJ, Malison RT, Owens MJ, Nemeroff CB, Price LH. "Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects." Neuropsychopharmacology, vol. 29, no. 4, 2004, pp. 777-84. |
| Carpenter LL, Heninger GR, Malison RT, Tyrka AR, Price LH. "Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression." Journal of affective disorders, vol. 79, no. 1-3, 2004, pp. 285-9. |
| Najjar F, Price LH. "Citalopram and dystonia." Journal of the American Academy of Child & Adolescent Psychiatry, vol. 43, no. 1, 2004, pp. 8-9. |
| Nelson JC, Mazure CM, Jatlow PI, Bowers MB Jr, Price LH. "Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study." Biological Psychiatry, vol. 55, no. 3, 2004, pp. 296-300. |
| Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH. "Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients." Biological Psychiatry, vol. 56, no. 6, 2004, pp. 418-26. |
| Tyrka AR, Carpenter LL, McDougle CJ, Kirwin PD, Owens MJ, Nemeroff CB, Strong DR, Price LH. "Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults." Biological Psychiatry, vol. 56, no. 7, 2004, pp. 531-4. |
| Lappalainen J, Sanacora G, Kranzler HR, Malison R, Hibbard ES, Price LH, Krystal J, Gelernter J. "Mutation screen of the glutamate decarboxylase-67 gene and haplotype association to unipolar depression." Am. J. Med. Genet., vol. 124B, no. 1, 2004, pp. 81-6. |
| Najjar F, Welch C, Grapentine WL, Sachs H, Siniscalchi J, Price LH. "Trends in psychotropic drug use in a child psychiatric hospital from 1991-1998." Journal of Child and Adolescent Psychopharmacology, vol. 14, no. 1, 2004, pp. 87-93. |
| Carpenter LL, Anderson GM, Siniscalchi JM, Chappell PB, Price LH. "Acute changes in cerebrospinal fluid 5-HIAA following oral paroxetine challenge in healthy humans." Neuropsychopharmacology, vol. 28, no. 2, 2003, pp. 339-47. |
| Carpenter LL, Friehs GM, Price LH. "Cervical vagus nerve stimulation for treatment-resistant depression." Neurosurgery Clinics of North America, vol. 14, no. 2, 2003, pp. 275-82. |
| Giambalvo CT, Price LH. "Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes." Synapse (New York, N.Y.), vol. 50, no. 3, 2003, pp. 212-22. |
| Greenberg BD, Price LH, Rauch SL, Friehs G, Noren G, Malone D, Carpenter LL, Rezai AR, Rasmussen SA. "Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues." Neurosurgery Clinics of North America, vol. 14, no. 2, 2003, pp. 199-212. |
| Marek GJ, Carpenter LL, McDougle CJ, Price LH. "Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders." Neuropsychopharmacology, vol. 28, no. 2, 2003, pp. 402-12. |
| Mello AF, Mello MF, Carpenter LL, Price LH. "Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis." Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), vol. 25, no. 4, 2003, pp. 231-8. |
| Carpenter LL, Yasmin S, Price LH. "A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine." Biological Psychiatry, vol. 51, no. 2, 2002, pp. 183-8. |
| Lappalainen J, Kranzler HR, Malison R, Price LH, Van Dyck C, Rosenheck RA, Cramer J, Southwick S, Charney D, Krystal J, Gelernter J. "A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States." Archives of General Psychiatry , vol. 59, no. 9, 2002, pp. 825-31. |
| Carpenter LL, Heninger GR, McDougle CJ, Tyrka AR, Epperson CN, Price LH. "Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania." Psychiatry Research, vol. 112, no. 3, 2002, pp. 257-62. |
| Carpenter LL, Leon Z, Yasmin S, Price LH. "Do obese depressed patients respond to topiramate? A retrospective chart review." Journal of affective disorders, vol. 69, no. 1-3, 2002, pp. 251-5. |
| Cubells JF, Price LH, Meyers BS, Anderson GM, Zabetian CP, Alexopoulos GS, Nelson JC, Sanacora G, Kirwin P, Carpenter L, Malison RT, Gelernter J. "Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression." Biological Psychiatry, vol. 51, no. 5, 2002, pp. 358-64. |
| Yasmin S, Carpenter LL, Leon Z, Siniscalchi JM, Price LH. "Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review." Journal of affective disorders, vol. 63, no. 1-3, 2001, pp. 243-7. |
| Eisen JL, Rasmussen SA, Phillips KA, Price LH, Davidson J, Lydiard RB, Ninan P, Piggott T. "Insight and treatment outcome in obsessive-compulsive disorder." Comprehensive Psychiatry, vol. 42, no. 6, 2001, pp. 494-7. |
| Eisen JL, Leonard HL, Swedo SE, Price LH, Zabriskie JB, Chiang SY, Karitani M, Rasmussen SA. "The use of antibody D8/17 to identify B cells in adults with obsessive-compulsive disorder." Psychiatry Research, vol. 104, no. 3, 2001, pp. 221-5. |
| Zhu J, Tulsky DS, Price L, Chen HY. "WAIS-III reliability data for clinical groups." Journal of the International Neuropsychological Society, vol. 7, no. 7, 2001, pp. 862-6. |
| McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH. "A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder." Archives of General Psychiatry , vol. 57, no. 8, 2000, pp. 794-801. |
| Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, Gelernter J. "A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia." Molecular Psychiatry, vol. 5, no. 1, 2000, pp. 56-63. |
| Price LH, Lebel J. "Dextromethorphan-induced psychosis." American Journal of Psychiatry, vol. 157, no. 2, 2000, pp. 304. |
| Gagné GG Jr, Furman MJ, Carpenter LL, Price LH. "Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients." American Journal of Psychiatry, vol. 157, no. 12, 2000, pp. 1960-5. |
| Desan PH, Oren DA, Malison R, Price LH, Rosenbaum J, Smoller J, Charney DS, Gelernter J. "Genetic polymorphism at the CLOCK gene locus and major depression." American journal of medical genetics, vol. 96, no. 3, 2000, pp. 418-21. |
| Carpenter LL, Price LH. "Psychotic depression: what is it and how should we treat it?." Harvard review of psychiatry, vol. 8, no. 1, 2000, pp. 40-2. |
| Carpenter LL, Leon Z, Yasmin S, Price LH. "Clinical experience with mirtazapine in the treatment of panic disorder." Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, vol. 11, no. 2, 1999, pp. 81-6. |
| Longhurst JG, Carpenter LL, Epperson CN, Price LH, McDougle CJ. "Effects of catecholamine depletion with AMPT (alpha-methyl-para-tyrosine) in obsessive-compulsive disorder." Biological Psychiatry, vol. 46, no. 4, 1999, pp. 573-6. |
| Goddard AW, Woods SW, Money R, Pande AC, Charney DS, Goodman WK, Heninger GR, Price LH. "Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder." Psychiatry Research, vol. 85, no. 3, 1999, pp. 225-40. |
| Calvocoressi L, Mazure CM, Kasl SV, Skolnick J, Fisk D, Vegso SJ, Van Noppen BL, Price LH. "Family accommodation of obsessive-compulsive symptoms: instrument development and assessment of family behavior." The Journal of Nervous and Mental Disease, vol. 187, no. 10, 1999, pp. 636-42. |
| Malison RT, Anand A, Pelton GH, Kirwin P, Carpenter L, McDougle CJ, Heninger GR, Price LH. "Limited efficacy of ketoconazole in treatment-refractory major depression." Journal of Clinical Psychopharmacology, vol. 19, no. 5, 1999, pp. 466-70. |
| Carpenter LL, Jocic Z, Hall JM, Rasmussen SA, Price LH. "Mirtazapine augmentation in the treatment of refractory depression." J. Clin. Psychiatry, vol. 60, no. 1, 1999, pp. 45-9. |
| Gordon A, Price LH. "Mood stabilization and weight loss with topiramate." American Journal of Psychiatry, vol. 156, no. 6, 1999, pp. 968-9. |
| Bruder GE, Wexler BE, Stewart JW, Price LH, Quitkin FM. "Perceptual asymmetry differences between major depression with or without a comorbid anxiety disorder: a dichotic listening study." Journal of Abnormal Psychology, vol. 108, no. 2, 1999, pp. 233-9. |
| McDougle CJ, Barr LC, Goodman WK, Price LH. "Possible role of neuropeptides in obsessive compulsive disorder." Psychoneuroendocrinology, vol. 24, no. 1, 1999, pp. 1-24. |
| Epperson CN, Fasula D, Wasylink S, Price LH, McDougle CJ. "Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases." Journal of Child and Adolescent Psychopharmacology, vol. 9, no. 1, 1999, pp. 43-9. |
| Price LH, Rasmussen SA, Eisen JL. "The natural history of obsessive-compulsive disorder." Archives of General Psychiatry , vol. 56, no. 2, 1999, pp. 131-2. |
| Phillips KA, Rasmussen SA, Price LH. "Treating imagined ugliness." Archives of General Psychiatry , vol. 56, no. 11, 1999, pp. 1041-2. |
| Malison RT, McCance E, Carpenter LL, Baldwin RM, Seibyl JP, Price LH, Kosten TR, Innis RB. "[123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts." Psychopharmacology, vol. 137, no. 4, 1998, pp. 321-5. |
| McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH. "A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders." Archives of General Psychiatry , vol. 55, no. 7, 1998, pp. 633-41. |
| Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, Price LH, Malison R, Rao PA, Kobayashi K, Nagatsu T, Gelernter J. "Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation." Human Genetics, vol. 102, no. 5, 1998, pp. 533-40. |
| Malison RT, Best SE, van Dyck CH, McCance EF, Wallace EA, Laruelle M, Baldwin RM, Seibyl JP, Price LH, Kosten TR, Innis RB. "Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT." American Journal of Psychiatry, vol. 155, no. 6, 1998, pp. 832-4. |
| McDougle CJ, Epperson CN, Price LH, Gelernter J. "Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder." Molecular Psychiatry, vol. 3, no. 3, 1998, pp. 270-3. |
| Calvocoressi L, Libman D, Vegso SJ, McDougle CJ, Price LH. "Global functioning of inpatients with obsessive-compulsive disorder, schizophrenia, and major depression." PS, vol. 49, no. 3, 1998, pp. 379-81. |
| Cappiello A, McDougle CJ, Delgado PL, Malison RT, Jatlow P, Charney DS, Heninger GR, Price LH. "Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study." International Clinical Psychopharmacology, vol. 13, no. 5, 1998, pp. 191-8. |
| Sernyak MJ, Glazer WM, Heninger GR, Charney DS, Woods SW, Petrakis IL, Krystal JH, Price LH. "Naltrexone augmentation of neuroleptics in schizophrenia." Journal of Clinical Psychopharmacology, vol. 18, no. 3, 1998, pp. 248-51. |
| Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS. "Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography." Biological Psychiatry, vol. 44, no. 11, 1998, pp. 1090-8. |
| Kosten TR, Cheeves C, Palumbo J, Seibyl JP, Price LH, Woods SW. "Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse." Drug and Alcohol Dependence, vol. 50, no. 3, 1998, pp. 187-95. |
| Narayan M, Anderson G, Cellar J, Mallison RT, Price LH, Nelson JC. "Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotonin." Journal of Clinical Psychopharmacology, vol. 18, no. 1, 1998, pp. 67-71. |
| McDougle CJ, Brodkin ES, Naylor ST, Carlson DC, Cohen DJ, Price LH. "Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation." Journal of Clinical Psychopharmacology, vol. 18, no. 1, 1998, pp. 62-6. |
| Price LH, Malison RT, McDougle CJ, Pelton GH, Heninger GR. "The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion." Biological Psychiatry, vol. 43, no. 5, 1998, pp. 339-47. |
| Carpenter LL, Anderson GM, Pelton GH, Gudin JA, Kirwin PD, Price LH, Heninger GR, McDougle CJ. "Tryptophan depletion during continuous CSF sampling in healthy human subjects." Neuropsychopharmacology, vol. 19, no. 1, 1998, pp. 26-35. |
| Rasmusson AM, Anderson GM, Lynch KA, McSwiggan-Hardin M, Scahill LD, Mazure CM, Goodman WK, Price LH, Cohen DJ, Leckman JF. "A preliminary study of tryptophan depletion on tics, obsessive-compulsive symptoms, and mood in Tourette's syndrome." Biological Psychiatry, vol. 41, no. 1, 1997, pp. 117-21. |
| Barr LC, Goodman WK, Anand A, McDougle CJ, Price LH. "Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder." American Journal of Psychiatry, vol. 154, no. 9, 1997, pp. 1293-5. |
| Kirwin PD, Anderson GM, Chappell PB, Saberski L, Leckman JF, Geracioti TD, Heninger GR, Price LH, McDougle CJ. "Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in healthy human females." Life sciences, vol. 60, no. 12, 1997, pp. 899-907. |
| Gelernter J, Van Dyck C, van Kammen DP, Malison R, Price LH, Cubells JF, Berman R, Charney DS, Heninger G. "Ciliary neurotrophic factor null allele frequencies in schizophrenia, affective disorders, and Alzheimer's disease." American journal of medical genetics, vol. 74, no. 5, 1997, pp. 497-500. |
| Brodkin ES, McDougle CJ, Naylor ST, Cohen DJ, Price LH. "Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigation." Journal of Child and Adolescent Psychopharmacology, vol. 7, no. 2, 1997, pp. 109-21. |
| Cappiello A, Sernyak MJ, Malison RT, McDougle CJ, Heninger GR, Price LH. "Effects of acute tryptophan depletion in lithium-remitted manic patients: a pilot study." Biological Psychiatry, vol. 42, no. 11, 1997, pp. 1076-8. |
| Price LH, Cappiello A, Malison RT, McDougle CJ, Pelton GH, Schöllnhammer G, Heninger GR. "Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects." Neuropsychopharmacology, vol. 17, no. 4, 1997, pp. 246-57. |
| Barr LC, Heninger GR, Goodman W, Charney DS, Price LH. "Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects." Biological Psychiatry, vol. 41, no. 9, 1997, pp. 949-54. |
| Malison RT, Price LH, Nestler EJ, Heninger GR, Duman RS. "Efficacy of papaverine addition for treatment-refractory major depression." American Journal of Psychiatry, vol. 154, no. 4, 1997, pp. 579-80. |
| Price LH, Malison RT, McDougle CJ, McCance-Katz EF, Owen KR, Heninger GR. "Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP)." Neuropsychopharmacology, vol. 17, no. 5, 1997, pp. 342-50. |
| Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS. "Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse." Archives of General Psychiatry , vol. 54, no. 4, 1997, pp. 364-74. |
| McDougle CJ, Holmes JP, Bronson MR, Anderson GM, Volkmar FR, Price LH, Cohen DJ. "Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study." Journal of the American Academy of Child & Adolescent Psychiatry, vol. 36, no. 5, 1997, pp. 685-93. |
| Price LH, Rasmussen SA. "Stress and depression: is neuroimmunology the missing link?." Harvard review of psychiatry, vol. 5, no. 2, 1997, pp. 108-12. |
| McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH. "A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder." Archives of General Psychiatry , vol. 53, no. 11, 1996, pp. 1001-8. |
| Carpenter LL, McDougle CJ, Epperson CN, Price LH. "A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder." Drug safety : an international journal of medical toxicology and drug experience, vol. 15, no. 2, 1996, pp. 116-34. |
| Price LH, Malison RT, McDougle CJ, Pelton GH. "Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential." CNS drugs, vol. 5, no. 5, 1996, pp. 311-20. |
| McDougle CJ, Naylor ST, Cohen DJ, Aghajanian GK, Heninger GR, Price LH. "Effects of tryptophan depletion in drug-free adults with autistic disorder." Archives of General Psychiatry , vol. 53, no. 11, 1996, pp. 993-1000. |
| Kosten TR, Kosten TA, McDougle CJ, Hameedi FA, McCance EF, Rosen MI, Oliveto AH, Price LH. "Gender differences in response to intranasal cocaine administration to humans." Biological Psychiatry, vol. 39, no. 2, 1996, pp. 147-8. |
| Geracioti TD Jr, Carpenter LL, Owens MJ, Baker DG, Ekhator NN, Horn PS, Strawn JR, Sanacora G, Kinkead B, Price LH, Nemeroff CB. "Intranasal oxytocin in obsessive-compulsive disorder." American Journal of Psychiatry, vol. 40, no. 4, 1996, pp. 547-9. |
| Epperson CN, McDougle CJ, Price LH. "Intranasal oxytocin in trichotillomania." Biological Psychiatry, vol. 40, no. 6, 1996, pp. 559-60. |
| McDougle CJ, Epperson CN, Price LH. "Obsessive-compulsive symptoms with-neuroleptics." Journal of the American Academy of Child & Adolescent Psychiatry, vol. 35, no. 7, 1996, pp. 837-8. |
| Cappiello A, Malison RT, McDougle CJ, Vegso SJ, Charney DS, Heninger GR, Price LH. "Seasonal variation in neuroendocrine and mood responses to i.v. L-tryptophan in depressed patients and healthy subjects." Neuropsychopharmacology, vol. 15, no. 5, 1996, pp. 475-83. |
| Hogarth L, English M, Price L, Wyllie R, Pearson AD, Hall AG. "The effect of treatment with high dose melphalan, cisplatin or carboplatin on levels of glutathione in plasma, erythrocytes, mononuclear cells and urine." Cancer chemotherapy and pharmacology, vol. 37, no. 5, 1996, pp. 479-85. |
| Brodkin ES, Pelton GH, Price LH. "Treatment of clozapine-induced parotid gland swelling." American Journal of Psychiatry, vol. 153, no. 3, 1996, pp. 445. |
| Malison RT, McDougle CJ, van Dyck CH, Scahill L, Baldwin RM, Seibyl JP, Price LH, Leckman JF, Innis RB. "[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder." American Journal of Psychiatry, vol. 152, no. 9, 1995, pp. 1359-61. |
| McDougle CJ, Kresch LE, Goodman WK, Naylor ST, Volkmar FR, Cohen DJ, Price LH. "A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder." American Journal of Psychiatry, vol. 152, no. 5, 1995, pp. 772-7. |
| Anand A, Malison R, McDougle CJ, Price LH. "Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report." Biological Psychiatry, vol. 37, no. 5, 1995, pp. 338-40. |
| Hameedi FA, Rosen MI, McCance-Katz EF, McMahon TJ, Price LH, Jatlow PI, Woods SW, Kosten TR. "Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans." Biological Psychiatry, vol. 37, no. 8, 1995, pp. 560-3. |
| McCance EF, Price LH, Kosten TR, Jatlow PI. "Cocaethylene: pharmacology, physiology and behavioral effects in humans." The Journal of pharmacology and experimental therapeutics, vol. 274, no. 1, 1995, pp. 215-23. |
| Goddard AW, Charney DS, Germine M, Woods SW, Heninger GR, Krystal JH, Goodman WK, Price LH. "Effects of tryptophan depletion on responses to yohimbine in healthy human subjects." Biological Psychiatry, vol. 38, no. 2, 1995, pp. 74-85. |
| Malison RT, Best SE, Wallace EA, McCance E, Laruelle M, Zoghbi SS, Baldwin RM, Seibyl JS, Hoffer PB, Price LH. "Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts." Psychopharmacology, vol. 122, no. 4, 1995, pp. 358-62. |
| Calvocoressi L, Lewis B, Harris M, Trufan SJ, Goodman WK, McDougle CJ, Price LH. "Family accommodation in obsessive-compulsive disorder." American Journal of Psychiatry, vol. 152, no. 3, 1995, pp. 441-3. |
| McDougle CJ, Barr LC, Goodman WK, Pelton GH, Aronson SC, Anand A, Price LH. "Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder." American Journal of Psychiatry, vol. 152, no. 12, 1995, pp. 1812-4. |
| Nelson JC, Price LH. "Lithium or desipramine augmentation of fluoxetine treatment." American Journal of Psychiatry, vol. 152, no. 10, 1995, pp. 1538-9. |
| Goodman WK, McDougle CJ, Price LH, Barr LC, Hills OF, Caplik JF, Charney DS, Heninger GR. "m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation." Biological Psychiatry, vol. 38, no. 3, 1995, pp. 138-49. |
| McDougle CJ, Krystal JH, Price LH, Heninger GR, Charney DS. "Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine." Psychopharmacology, vol. 118, no. 2, 1995, pp. 127-35. |
| Krystal JH, Woods SW, Kosten TR, Rosen MI, Seibyl JP, van Dyck CC, Price LH, Zubal IG, Hoffer PB, Charney DS. "Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT)." The American Journal of Drug and Alcohol Abuse, vol. 21, no. 1, 1995, pp. 47-63. |
| Price LH, Spencer DD, Marek KL, Robbins RJ, Leranth C, Farhi A, Naftolin F, Roth RH, Bunney BS, Hoffer PB. "Psychiatric status after human fetal mesencephalic tissue transplantation in Parkinson's disease." Biological Psychiatry, vol. 38, no. 8, 1995, pp. 498-505. |
| Coreil J, Price L, Barkey N. "Recognition and management of teething diarrhea among Florida pediatricians." Clinical Pediatrics, vol. 34, no. 11, 1995, pp. 591-8. |
| McDougle CJ, Fleischmann RL, Epperson CN, Wasylink S, Leckman JF, Price LH. "Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases." J. Clin. Psychiatry, vol. 56, no. 11, 1995, pp. 526-8. |
| Aronson SC, Black JE, McDougle CJ, Scanley BE, Jatlow P, Kosten TR, Heninger GR, Price LH. "Serotonergic mechanisms of cocaine effects in humans." Psychopharmacology, vol. 119, no. 2, 1995, pp. 179-85. |
| Cappiello A, McDougle CJ, Malison RT, Heninger GR, Price LH. "Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study." Biological Psychiatry, vol. 38, no. 11, 1995, pp. 765-7. |
| Rosen MI, Wallace EA, McMahon TJ, Pearsall HR, Woods SW, Price LH, Kosten TR. "Buprenorphine: duration of blockade of effects of intramuscular hydromorphone." Drug and Alcohol Dependence, vol. 35, no. 2, 1994, pp. 141-9. |
| Wexler BE, Levenson L, Warrenburg S, Price LH. "Decreased perceptual sensitivity to emotion-evoking stimuli in depression." Psychiatry Research, vol. 51, no. 2, 1994, pp. 127-38. |
| McDougle CJ, Goodman WK, Price LH. "Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder." J. Clin. Psychiatry, vol. 55 Suppl, 1994, pp. 24-31. |
| Goddard AW, Sholomskas DE, Walton KE, Augeri FM, Charney DS, Heninger GR, Goodman WK, Price LH. "Effects of tryptophan depletion in panic disorder." Biological Psychiatry, vol. 36, no. 11, 1994, pp. 775-7. |
| Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ. "Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls." Archives of General Psychiatry , vol. 51, no. 10, 1994, pp. 782-92. |
| McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. "Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics." Archives of General Psychiatry , vol. 51, no. 4, 1994, pp. 302-8. |
| Price LH, Heninger GR. "Lithium in the treatment of mood disorders." New England Journal of Medicine, vol. 331, no. 9, 1994, pp. 591-8. |
| Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH. "Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects." American Journal of Psychiatry, vol. 151, no. 11, 1994, pp. 1626-30. |
| McDougle CJ, Black JE, Malison RT, Zimmermann RC, Kosten TR, Heninger GR, Price LH. "Noradrenergic dysregulation during discontinuation of cocaine use in addicts." Archives of General Psychiatry , vol. 51, no. 9, 1994, pp. 713-9. |
| Holzer JC, Goodman WK, McDougle CJ, Baer L, Boyarsky BK, Leckman JF, Price LH. "Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients." The British Journal of Psychiatry, vol. 164, no. 4, 1994, pp. 469-73. |
| Barr LC, Goodman WK, Price LH. "Physical symptoms associated with paroxetine discontinuation." American Journal of Psychiatry, vol. 151, no. 2, 1994, pp. 289. |
| Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR, Charney DS. "Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients." Archives of General Psychiatry , vol. 51, no. 11, 1994, pp. 865-74. |
| Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McDougle CJ, Barr LC. "The role of central oxytocin in obsessive compulsive disorder and related normal behavior." Psychoneuroendocrinology, vol. 19, no. 8, 1994, pp. 723-49. |
| Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH. "Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors." Archives of General Psychiatry , vol. 51, no. 4, 1994, pp. 309-17. |
| McDougle CJ, Naylor ST, Goodman WK, Volkmar FR, Cohen DJ, Price LH. "Acute tryptophan depletion in autistic disorder: a controlled case study." Biological Psychiatry, vol. 33, no. 7, 1993, pp. 547-50. |
| Goodman WK, McDougle CJ, Barr LC, Aronson SC, Price LH. "Biological approaches to treatment-resistant obsessive compulsive disorder." J. Clin. Psychiatry, vol. 54 Suppl, 1993, pp. 16-26. |
| Redmond DE Jr, Robbins RJ, Naftolin F, Marek KL, Vollmer TL, Leranth C, Roth RH, Price LH, Gjedde A, Bunney BS. "Cellular replacement of dopamine deficit in Parkinson's disease using human fetal mesencephalic tissue: preliminary results in four patients." Research publications - Association for Research in Nervous and Mental Disease, vol. 71, 1993, pp. 325-59. |
| McCance-Katz EF, Price LH, McDougle CJ, Kosten TR, Black JE, Jatlow PI. "Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene." Psychopharmacology, vol. 111, no. 1, 1993, pp. 39-46. |
| Rosen MI, Pearsall HR, McDougle CJ, Price LH, Woods SW, Kosten TR. "Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study." The American Journal of Drug and Alcohol Abuse, vol. 19, no. 4, 1993, pp. 451-64. |
| Zimmermann RC, McDougle CJ, Schumacher M, Olcese J, Mason JW, Heninger GR, Price LH. "Effects of acute tryptophan depletion on nocturnal melatonin secretion in humans." The Journal of Clinical Endocrinology & Metabolism, vol. 76, no. 5, 1993, pp. 1160-4. |
| Calvocoressi L, McDougle CI, Wasylink S, Goodman WK, Trufan SJ, Price LH. "Inpatient treatment of patients with severe obsessive-compulsive disorder." Hospital & community psychiatry, vol. 44, no. 12, 1993, pp. 1150-4. |
| McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH. "Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder." American Journal of Psychiatry, vol. 150, no. 4, 1993, pp. 647-9. |
| Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK, Charney DS. "m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia." Archives of General Psychiatry , vol. 50, no. 8, 1993, pp. 624-35. |
| Nandabalan K, Price L, Roeder GS. "Mutations in U1 snRNA bypass the requirement for a cell type-specific RNA splicing factor." Cell, vol. 73, no. 2, 1993, pp. 407-15. |
| Sherman TL, McDougle CJ, Price LH. "Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression." Connecticut medicine, vol. 57, no. 9, 1993, pp. 587-92. |
| McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. "The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder." Journal of Clinical Psychopharmacology, vol. 13, no. 5, 1993, pp. 354-8. |
| McDougle CJ, Goodman WK, Price LH. "The pharmacotherapy of obsessive-compulsive disorder." Pharmacopsychiatry, vol. 26 Suppl 1, 1993, pp. 24-9. |
| McDougle CJ, Goodman WK, Leckman JF, Price LH. "The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis." Psychiatric Clinics of North America, vol. 16, no. 4, 1993, pp. 749-66. |
| Barr LC, Goodman WK, Price LH. "The serotonin hypothesis of obsessive compulsive disorder." International Clinical Psychopharmacology, vol. 8 Suppl 2, 1993, pp. 79-82. |
| Zimmermann RC, McDougle CJ, Schumacher M, Olcese J, Heninger GR, Price LH. "Urinary 6-hydroxymelatonin sulfate as a measure of melatonin secretion during acute tryptophan depletion." Psychoneuroendocrinology, vol. 18, no. 8, 1993, pp. 567-78. |
| Marek GJ, McDougle CJ, Price LH, Seiden LS. "A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action." Psychopharmacology, vol. 109, no. 1-2, 1992, pp. 2-11. |
| Barr LC, Goodman WK, Price LH. "Acute exacerbation of body dysmorphic disorder during tryptophan depletion." American Journal of Psychiatry, vol. 149, no. 10, 1992, pp. 1406-7. |
| Goodman WK, Price LH. "Assessment of severity and change in obsessive compulsive disorder." Psychiatric Clinics of North America, vol. 15, no. 4, 1992, pp. 861-9. |
| Krystal JH, McDougle CJ, Kosten TR, Price LH, Aghajanian GK, Charney DS. "Baclofen-assisted detoxification from opiates. A pilot study." Journal of Substance Abuse Treatment, vol. 9, no. 2, 1992, pp. 139-42. |
| Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR. "Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?." The American Journal of Drug and Alcohol Abuse, vol. 18, no. 3, 1992, pp. 331-41. |
| McDougle CJ, Price LH, Volkmar FR, Goodman WK, Ward-O'Brien D, Nielsen J, Bregman J, Cohen DJ. "Clomipramine in autism: preliminary evidence of efficacy." Journal of the American Academy of Child & Adolescent Psychiatry, vol. 31, no. 4, 1992, pp. 746-50. |
| McCance-Katz EF, Price LH. "Depression associated with vitamin A intoxication." Psychosomatics, vol. 33, no. 1, 1992, pp. 117-8. |
| McDougle CJ, Price LH, Palumbo JM, Kosten TR, Heninger GR, Kleber HD. "Dopaminergic responsivity during cocaine abstinence: a pilot study." Psychiatry Research, vol. 43, no. 1, 1992, pp. 77-85. |
| Krystal JH, McDougle CJ, Woods SW, Price LH, Heninger GR, Charney DS. "Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine." Psychopharmacology, vol. 108, no. 3, 1992, pp. 313-9. |
| Goodman WK, McDougle CJ, Price LH. "Pharmacotherapy of obsessive compulsive disorder." J. Clin. Psychiatry, vol. 53 Suppl, 1992, pp. 29-37. |
| McCance-Katz EF, Marek KL, Price LH. "Serotonergic dysfunction in depression associated with Parkinson's disease." Neurology, vol. 42, no. 9, 1992, pp. 1813-4. |
| McCance-Katz E, Price LH, Charney DS, Heninger GR. "Serotonergic function during lithium augmentation of refractory depression." Psychopharmacology, vol. 108, no. 1-2, 1992, pp. 93-7. |
| Price LH, Charney DS, Heninger GR. "Serotonin syndrome." American Journal of Psychiatry, vol. 149, no. 8, 1992, pp. 1116-7. |
| Goodman WK, McDougle CJ, Price LH. "The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder." International Clinical Psychopharmacology, vol. 7 Suppl 1, 1992, pp. 35-8. |
| Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS. "The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies." J. Clin. Psychiatry, vol. 53 Suppl, 1992, pp. 17-28. |
| Heninger GR, Delgado PL, Charney DS, Price LH, Aghajanian GK. "Tryptophan-deficient diet and amino acid drink deplete plasma tryptophan and induce a relapse of depression in susceptible patients." Journal of chemical neuroanatomy, vol. 5, no. 4, 1992, pp. 347-8. |
| Spencer DD, Robbins RJ, Naftolin F, Marek KL, Vollmer T, Leranth C, Roth RH, Price LH, Gjedde A, Bunney BS. "Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease." New England Journal of Medicine, vol. 327, no. 22, 1992, pp. 1541-8. |
| McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR. "A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy." Journal of Clinical Psychopharmacology, vol. 11, no. 3, 1991, pp. 175-84. |
| Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD. "Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study." American Journal of Psychiatry, vol. 148, no. 12, 1991, pp. 1712-6. |
| Seibyl JP, Krystal JH, Price LH, Woods SW, D'Amico C, Heninger GR, Charney DS. "Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects." Psychiatry Research, vol. 38, no. 3, 1991, pp. 227-36. |
| Delgado PL, Price LH, Miller HL, Salomon RM, Licinio J, Krystal JH, Heninger GR, Charney DS. "Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression." Psychopharmacology bulletin, vol. 27, no. 3, 1991, pp. 321-30. |
| Price LH, Charney DS, Delgado PL, Heninger GR. "Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects." American Journal of Psychiatry, vol. 148, no. 11, 1991, pp. 1518-25. |
| Woods SW, O'Malley SS, Martini BL, McDougle CJ, Price LH, Krystal JH, Hoffer PB, Kosten TR. "SPECT regional cerebral blood flow and neuropsychological testing in non-demented HIV-positive drug abusers: preliminary results." Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 15, no. 5, 1991, pp. 649-62. |
| Nierenberg AA, Price LH, Charney DS, Heninger GR. "After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression." Journal of affective disorders, vol. 18, no. 3, 1990, pp. 167-75. |
| Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF. "Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?." J. Clin. Psychiatry, vol. 51 Suppl, 1990, pp. 36-43; discussion 55-8. |
| Price LH, Charney DS, Delgado PL, Goodman WK, Krystal JH, Woods SW, Heninger GR. "Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs." J. Clin. Psychiatry, vol. 51 Suppl, 1990, pp. 44-50; discussion 51-2. |
| Price LH, Charney DS, Delgado PL, Goodman WK, Krystal JH, Woods SW, Heninger GR. "Clinical studies of 5-HT function using i.v. L-tryptophan." Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 14, no. 4, 1990, pp. 459-72. |
| Price LH, Charney DS, Delgado PL, Heninger GR. "Fenfluramine augmentation in tricyclic-refractory depression." Journal of Clinical Psychopharmacology, vol. 10, no. 5, 1990, pp. 312-7. |
| McDougle CJ, Price LH, Goodman WK. "Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report." Journal of Autism and Developmental Disorders, vol. 20, no. 4, 1990, pp. 537-43. |
| Delgado PL, Goodman WK, Price LH, Heninger GR, Charney DS. "Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder." The British Journal of Psychiatry, vol. 157, 1990, pp. 762-5. |
| Price LH, Charney DS, Delgado PL, Heninger GR. "Lithium and serotonin function: implications for the serotonin hypothesis of depression." Psychopharmacology, vol. 100, no. 1, 1990, pp. 3-12. |
| McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS, Heninger GR. "Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder." American Journal of Psychiatry, vol. 147, no. 5, 1990, pp. 652-4. |
| Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD. "Opioid antagonist challenges in buprenorphine maintained patients." Drug and Alcohol Dependence, vol. 25, no. 1, 1990, pp. 73-8. |
| Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. "Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan." Archives of General Psychiatry , vol. 47, no. 5, 1990, pp. 411-8. |
| Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS. "Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine." Archives of General Psychiatry , vol. 47, no. 6, 1990, pp. 577-85. |
| Price LH, Charney DS, Delgado PL, Anderson GM, Heninger GR. "Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action." Archives of General Psychiatry , vol. 46, no. 7, 1989, pp. 625-31. |
| Heninger GR, Charney DS, Price LH, Delgado P, Woods S, Goodman W. "Effects of serotonergic agonists on neuroendocrine responses of rhesus monkeys and patients with depression and anxiety disorders." Psychopharmacology series, vol. 7, 1989, pp. 94-104. |
| Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. "Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo." Archives of General Psychiatry , vol. 46, no. 1, 1989, pp. 36-44. |
| Goodman WK, Price LH, Rasmussen SA, Heninger GR, Charney DS. "Fluvoxamine as an antiobsessional agent." Psychopharmacology bulletin, vol. 25, no. 1, 1989, pp. 31-5. |
| Price LH, Charney DS, Delgado PL, Heninger GR. "Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder." Archives of General Psychiatry , vol. 46, no. 1, 1989, pp. 13-9. |
| Delgado PL, Charney DS, Price LH, Landis H, Heninger GR. "Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects." Life sciences, vol. 45, no. 24, 1989, pp. 2323-32. |
| Price LH, Ricaurte GA, Krystal JH, Heninger GR. "Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations." Archives of General Psychiatry , vol. 46, no. 1, 1989, pp. 20-2. |
| McDougle CJ, Goodman WK, Delgado PL, Price LH. "Pathophysiology of obsessive-compulsive disorder." American Journal of Psychiatry, vol. 146, no. 10, 1989, pp. 1350-1. |
| Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD. "Rapid detoxification from opioid dependence." American Journal of Psychiatry, vol. 146, no. 10, 1989, pp. 1349. |
| Price LH, Ricaurte GA, Krystal JH, Heninger GR. "Responses to i.v. L-tryptophan in MDMA users." NIDA research monograph, vol. 95, 1989, pp. 421-2. |
| Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. "The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability." Archives of General Psychiatry , vol. 46, no. 11, 1989, pp. 1006-11. |
| Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. "The Yale-Brown Obsessive Compulsive Scale. II. Validity." Archives of General Psychiatry , vol. 46, no. 11, 1989, pp. 1012-6. |
| Seibyl JP, Krystal JH, Price LH, Charney DS. "Use of yohimbine to counteract nortriptyline-induced orthostatic hypotension." Journal of Clinical Psychopharmacology, vol. 9, no. 1, 1989, pp. 67-8. |
| Price LH. "What is the duration for augmentation with T3 or lithium in resistant depression?." Journal of Clinical Psychopharmacology, vol. 9, no. 1, 1989, pp. 73. |
| Heninger GR, Charney DS, Price LH. "alpha 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine." Archives of General Psychiatry , vol. 45, no. 8, 1988, pp. 718-26. |
| Price LH, Heninger GR. "Can yohimbine be used to treat orthostatic hypotension associated with the use of desipramine and other antidepressants? What general and/or specific strategy do you recommend for treating orthostatic hypotension?." Journal of Clinical Psychopharmacology, vol. 8, no. 5, 1988, pp. 384. |
| Price LH, Charney DS, Heninger GR. "Effects of trazodone treatment on serotonergic function in depressed patients." Psychiatry Research, vol. 24, no. 2, 1988, pp. 165-75. |
| Delgado PL, Price LH, Charney DS, Heninger GR. "Efficacy of fluvoxamine in treatment-refractory depression." Journal of affective disorders, vol. 15, no. 1, 1988, pp. 55-60. |
| Salloway S, Price LH, Charney DS, Shapiro M. "Multiple sclerosis presenting as major depression: a diagnosis suggested by MRI scan but not CT scan." J. Clin. Psychiatry, vol. 49, no. 9, 1988, pp. 364-6. |
| Heninger GR, Charney DS, Price LH. "Noradrenergic and serotonergic receptor system function in panic disorder and depression." Acta psychiatrica Scandinavica. Supplementum, vol. 341, 1988, pp. 138-50. |
| Palumbo JM, Price LH. "Opening the mouth to abolish auditory hallucinations." American Journal of Psychiatry, vol. 145, no. 6, 1988, pp. 767. |
| Price LH, Delgado PL, Charney DS, Heninger GR. "Sequence of drug administration in lithium augmentation: a case study." J. Clin. Psychiatry, vol. 49, no. 4, 1988, pp. 161-2. |
| Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR. "Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects." Archives of General Psychiatry , vol. 45, no. 2, 1988, pp. 177-85. |
| Price LH. "Mania induced by lithium augmentation." American Journal of Psychiatry, vol. 144, no. 3, 1987, pp. 389. |
| Price LH, Charney DS, Heninger GR. "Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects." Psychopharmacology, vol. 92, no. 4, 1987, pp. 431-7. |
| Price LH, Goodman WK, Charney DS, Rasmussen SA, Heninger GR. "Treatment of severe obsessive-compulsive disorder with fluvoxamine." American Journal of Psychiatry, vol. 144, no. 8, 1987, pp. 1059-61. |
| Price LH, Nelson JC. "Alcoholism and affective disorder." American Journal of Psychiatry, vol. 143, no. 8, 1986, pp. 1067-8. |
| Price LH, Charney DS, Rubin AL, Heninger GR. "Alpha 2-adrenergic receptor function in depression. The cortisol response to yohimbine." Archives of General Psychiatry , vol. 43, no. 9, 1986, pp. 849-58. |
| Charney DS, Price LH, Heninger GR. "Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action." Archives of General Psychiatry , vol. 43, no. 12, 1986, pp. 1155-61. |
| Innis RB, Bunney BS, Charney DS, Price LH, Glazer WM, Sternberg DE, Rubin AL, Heninger GR. "Does the cholecystokinin antagonist proglumide possess antipsychotic activity?." Psychiatry Research, vol. 18, no. 1, 1986, pp. 1-7. |
| Price LH, Charney DS, Heninger GR. "Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients." Psychopharmacology, vol. 89, no. 1, 1986, pp. 38-44. |
| Goodman WK, Charney DS, Price LH, Woods SW, Heninger GR. "Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases." American Journal of Psychiatry, vol. 143, no. 7, 1986, pp. 900-3. |
| Charney DS, Heninger GR, Price LH, Breier A. "Major depression and panic disorder: diagnostic and neurobiological relationships." Psychopharmacology bulletin, vol. 22, no. 2, 1986, pp. 503-11. |
| Nelson JC, Price LH, Jatlow PI. "Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression." American Journal of Psychiatry, vol. 143, no. 9, 1986, pp. 1151-4. |
| Mazure C, Nelson JC, Price LH. "Reliability and validity of the symptoms of major depressive illness." Archives of General Psychiatry , vol. 43, no. 5, 1986, pp. 451-6. |
| Price LH, Charney DS, Heninger GR. "Variability of response to lithium augmentation in refractory depression." American Journal of Psychiatry, vol. 143, no. 11, 1986, pp. 1387-92. |
| Colby BN, Aldwin CM, Price L, Stegemann C, Mishra S. "Adaptive potential, stress, and illness in the elderly." Medical Anthropology, vol. 9, no. 4, 1985, pp. 283-95. |
| Price LH, Charney DS, Heninger GR. "Effects of tranylcypromine treatment on neuroendocrine, behavioral, and autonomic responses to tryptophan in depressed patients." Life sciences, vol. 37, no. 9, 1985, pp. 809-18. |
| Price LH, Charney DS, Heninger GR. "Efficacy of lithium-tranylcypromine treatment in refractory depression." American Journal of Psychiatry, vol. 142, no. 5, 1985, pp. 619-23. |
| Rubin AL, Price LH, Charney DS, Heninger GR. "Noradrenergic function and the cortisol response to dexamethasone in depression." Psychiatry Research, vol. 15, no. 1, 1985, pp. 5-15. |
| Rubin AL, Charney DS, Price LH, Heninger GR. "Rapid improvement of delusional depression following drug-induced seizures: case report." J. Clin. Psychiatry, vol. 46, no. 4, 1985, pp. 146-7. |
| Price LH, Nelson JC, Jatlow PI. "Effects of desipramine on clinical liver function tests." American Journal of Psychiatry, vol. 141, no. 6, 1984, pp. 798-800. |
| Price LH, Nelson JC, Charney DS, Quinlan DM. "Family history in delusional depression." Journal of affective disorders, vol. 6, no. 1, 1984, pp. 109-14. |
| Price LH, Charney DS, Heninger GR. "Manic symptoms following addition of lithium to antidepressant treatment." Journal of Clinical Psychopharmacology, vol. 4, no. 6, 1984, pp. 361-2. |
| Price LH, Nelson JC, Charney DS, Quinlan DM. "The clinical utility of family history for the diagnosis of melancholia." The Journal of Nervous and Mental Disease, vol. 172, no. 1, 1984, pp. 5-11. |
| Price LH, Charney DS, Heninger GR. "Three cases of manic symptoms following yohimbine administration." American Journal of Psychiatry, vol. 141, no. 10, 1984, pp. 1267-8. |
| Price LH, Nelson JC, Waltrip RW. "Desipramine-associated hepatitis." Journal of Clinical Psychopharmacology, vol. 3, no. 4, 1983, pp. 243-6. |
| Price LH, Conwell Y, Nelson JC. "Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression." American Journal of Psychiatry, vol. 140, no. 3, 1983, pp. 318-22. |
| Leigh H, Price L, Ciarcia J, Mirassou MM. "DSM III and consultation-liaison psychiatry: toward a comprehensive medical model of the patient." General Hospital Psychiatry, vol. 4, no. 4, 1982, pp. 283-9. |
| Ridout, Samuel J., Ridout, Kathryn K., Kao, Hung-Teh, Carpenter, Linda L., Philip, Noah S., Tyrka, Audrey R., Price, Lawrence H. "Telomeres, early-life stress and mental illness." Advances in psychosomatic medicine, vol. 34, 1900, pp. 92-108. |
GRANTS
1. University of Michigan Student Medical Research Grant, "Computer simulation of motivation and action," Princ. Investig.; 6/75-8/75, $900.
2. NIMH P50 MH30929, "Clinical Science Research Center in Psychiatry," Co-investig.; 9/77-8/97, $3,425,686 [most recent funding cycle].
3. NIMH P01 MH25642, "Neurobiologic basis of major psychiatric disorders," Co-investig.;7/78-6/96, $3,458,203 [most recent funding cycle].
4. NIMH R01 MH36229, "Monoamine receptor sensitivity and antidepressant drugs," Co-investig.; 4/82-8/92, $357,469 [most recent funding cycle].
5. NIDA P05 DA04060, "Clinical Research Center for Opioid and Cocaine Use" (Component: "Clinical neurobiology of cocaine withdrawal and administration"), Component Princ. Investig.; 8/86-7/96, $619,142 [most recent funding cycle].
6. CIBA-GEIGY Pharmaceuticals, "Anafranil vs. placebo in the treatment of OCD - Extension Phase," Princ. Investig.; 6/87-1/89, $36,500.
7. NIMH K08 MH00579 (Clinical Investigator Award), "Neurobiology and treatment of refractory depression," Princ. Investig.; 8/87-7/90, $160,474.
8. Pfizer Pharmaceuticals, "Double-blind comparison of SM-3997 and placebo in outpatients with depression," Princ. Investig.; 5/88-6/90, $60,600.
9. NIDA R18 DA06190, "Treatment Research Unit: Reducing AIDS risk by pharmaco- and psychotherapy," Co-investig.; 8/89-9/94, $2,685,673.
10. NIMH R01 MH47894, "Rapid treatment of major depression, " Co-investig.; 5/92-4/95, $461,143.
11. Parke-Davis, "A single-blind, placebo-controlled crossover study of oral CI-988 for anxiety in patients with GAD," Princ. Investig.; 5/92-6/93, $36,980.
12. Miles Pharmaceuticals, "A multicenter, double-blind, placebo-controlled, parallel-group study of the safety, tolerability, and efficacy of three fixed doses of ipsapirone CR (Bay Q7821) vs placebo in outpatients with moderate to severe major depressive disorder (MDD)," Princ. Investig.; 8/93-8/94, $124,800.
13. Stanley Foundation Research Awards Program, National Alliance for the Mentally Ill, "The role of monoaminergic function in the mechanism of action of lithium in mania," Princ. Investig.; 8/94-8/96, $128,000.
14. NIDA R01 DA09330-01, "Serotonin/dopamine antagonism of cocaine effect," Princ. Investig.; 9/94-8/97, $673,686; extended to 8/98, with administrative increase of $55,532.
15. Solvay Pharmaceuticals, Unrestricted grant, Princ. Investig.; 5/95, $50,000.
16. Departmental Research Award, Brown Univ. Dept. of Psychiatry and Human Behavior, "The genetics of dopamine -hydroxylase in psychotic and nonpsychotic depression," Princ. Investig.; 7/97 - 6/98, $15,888.
17. Solvay Pharmaceuticals, "A multicenter, double-blind, placebo-controlled, parallel group study of the safety, tolerability and efficacy of three fixed doses of fluvoxamine vs placebo in outpatients with major depressive disorder," Princ. Investig.; 9/97 - 8/98, $242,120.
18. Pfizer, Inc., "A phase III, randomized, placebo-controlled study evaluating the safey and outcome of treatment with oral ziprasidone in subjects with mania receiving lithium," Princ. Investig.; 1/98 - 1/99, $169,313.
19. Pfizer, Inc., "An open extension study evaluating the safety and outcome of 40-160 mg daily of oral ziprasidone in the treatment of subjects who have participated in Protocol 602," Princ. Investig.; 1/98 - 1/00, $36,300.
20. Forest Laboratories, Inc., "An open-label evaluation of the efficacy, safety, and dosing of citalopram in outpatients with depression," Princ. Investig.; 2/98 - 3/99, $40,040.
21. Forest Laboratories, Inc.,"An open-label extension of citalopram treatment in outpatients with depression," Princ. Investig; 3/98- 3/99, $29,912.
22. Eli Lilly and Co., "Comparative efficacy of switching SSRI nonresponders to fluoxetine vs continued antidepressant treatment with the same SSRI," Princ. Investig.; 3/98 - 3/00, $74,961.
23. Pfizer, Inc., "Validation of serial CSF collection method for assessment of central serotonergic function," Princ. Investig.; 7/98 - 10/98, $47,956.
24. Merck Research Laboratories, "A double-blind, multicenter study of two doses of L-759274 vs paroxetine hydrochloride and placebo in the treatment of outpatients with major depressive disorder," Investigator; 8/99 - 3/00, $197,520.
25. Pfizer, Inc., "A six-week, double-blind, placebo-controlled, multicenter study to evaluate the safety and efficacy of 3 doses of CP-448,187 (0.5, 3, and 10 mg) and fluoxetine (Prozac) in subjects with major depressive disorder," Princ. Investig.; 5/00- 5/02, $82,797.
26. NIMH RO1 MH58866-01, "Combined treatment for depressed inpatients," Co-Princ. Investig.; 6/00 7/05, $2,352,122.
27. NCI R21 CA88297-01, "Behavioral vulnerability to early smoking relapse," Co-Investig.; 7/00 6/02, $362,500.
28. Cyberonics, "A multicenter, pivotal, safety and efficacy study of the NeuroCybernetic Prosthesis (NCP) system in patients with depression," Co-Investig., 2/00-2/02, $117,145.
29. Cyberonics, "A long-term, prospective, multicenter study to compare the clinical, quality of life, and health care utilization outcomes of the NeuroCyberonic Prosthesis (NCP) System to the standard of care treatment in patients with depression," Co-Investig., 1/01-1/03, $61,680.
30. Cyberonics, "CSF neurochemical correlates of vagus nerve stimulation in depressed patients," Co-Investig., 1/01-1/03, $108,725.
31. Thuris Corp., "Evoked response potentials in mood disorders. I.," Princ. Investig.; 6/01-6/02, $10,000.
32. Scirex Corp./Corcept Therapeutics, Inc., "1073-02: A phase III, randomized, double-blind, placebo-controlled study of the safety and efficacy of C-1073 (mifepristone) in patients with major depressive disorder with psychotic features," Co-Investig., 11/01-11/02, $14,967.
33. Scirex Corp./Corcept Therapeutics, Inc., "1073-02: A phase III, randomized, double-blind, placebo-controlled study of the safety and efficacy of C-1073 (mifepristone) in patients with major depressive disorder with psychotic features who are not receiving antidepressants or antipsychotics," Co-Investig., 11/01-11/02, $14,967
34. Merck Research Laboratories, "A worldwide, multicenter, double-blind, parallel, active-controlled, long-term safety study of MK-0869 in outpatients with major depressive disorder (Protocol 066-00)," Princ. Investig.; 2/02-2/03, $251,880.
35. Cephalon, Inc. "An open-label, 8-week study with flexible doses of Gabitril (tiagabine hydrochloride) in patients with major depressive disorder with anxiety (MDD-A)," Co-Investig., 3/02-3/03, $127,500.
36. Thuris Corp., "Evoked response potentials in mood disorders. II.," Princ. Investig.; 7/02-8/03, $45,555.
37. American Cancer Society RSGPB PBP-103382, "Improving smoking cessation in smokers with depressive symptoms," Co-Investig., 7/02-6/06, $1,264,374.
38. Medtronic, Inc., "Electrical Stimulation of the Anterior Limb of the Internal Capsule to Treat Major Depressive Disorder," Co-Investig., 10/02-9/04, $315,000.
39. Pfizer, Inc., "Sertraline treatment and cortisol response to the DEX/CRH test in healthy subjects," Co-Investig., 12/03-12/06, $125,260.
40. NIMH RO1 MH068767-01, "DEX/CRH response: Mood/anxiety disorder endophenotype?," Co-Investig.; 4/043/08, $1,227,776.
41. NCCAM/NIMH RO1 AT001742-01, "Double-blind, placebo-controlled study of SAMe vs. escitalopram in MDD," Princ. Investig.; 4/04-3/09, $1,087,938.
42. US Dept of Defense, "Perceived early life stress and DEX/CRH test response as predictors of psychological sequelae following exposure of healthy adults to war stress," Co-Investig.; 7/046/05, $40,000.
43. UCB Pharma, Inc., "Keppra treatment and cortisol response to the DEX/CRH test in healthy subjects," Co-Investig.; 6/0412/06, $111,624.
44. Sepracor, Inc. ESRC101, "Eszopiclone treatment and cortisol response to HPA Axis tests," Co-Investig; 9/066/08, $254,319.
45. Cyberonics, Inc., "Randomized comparison of outcomes in patients with treatment-resistant depression who receive VNS therapy administered at different amounts of electrical charge," Co-Investig., 11/07-9/10; $286,350.
46. NIDA RO1 DA023190-01A1, "Sequential use of fluoxetine for smokers with elevated depressive symptoms," Co-Investig.; 9/073/12, $2,374,108.
47. Medtronic, Inc., "RECLAIM deep brain stimulation (DBS) clinical study for treatment-resistant depression," Co-Investig., 4/09-6/11.
48. Neuronetics, Inc., "NeuroStar Transcranial Magnetic Stimulation Therapy® System: Data management, analysis and reporting format for clinical treatment utilization and outcomes," Co-Investig., 9/099/10.
49. HRSA C76HF19883, "Health care and other facilities (Butler Hospital's Center for Advanced Diagnostics and Therapeutics In Alzheimer's Disease)," Progr. Dir.; 9/10-9/11, $198,000.
50. NIMH R21 MH091508, "Childhood Maltreatment: Epigenetic Modulation of the Glucocorticoid Receptor," Co-Investig., 4/11-3/13; $388,694.
51. NeoSync, Inc. "Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter Randomized, Double-Blind, Sham-Controlled, Trial," Co-Investig., 4/11-4/14.
52. Neuronetics, Inc., “Protocol 44-03001-000 Maintenance NeuroStar TMS in patients with major depressive disorder,” Co-Investig., 3/12-1/14.
53. NIMH R01 MH095786, "Multi-method assessment of emotion reactivity: Translational research in suicide," Co-Investig., 7/12-4/17, $1,945,063.
54. NIDA R34 DA034312, "Brief computer intervention to motivate quitline use for smokers in SUD treatment," Co-Investig.; 8/12-7/14, $595,557.
55. NCI R01 CA173551, "Aerobic Exercise for Smokers with Depressive Symptomatology," Co-Investig.; 9/13-6/18, $3,374,088.
56. NIMH R01 MH102000, "Technology-assisted assessment of post-hospital adherence in schizophrenia," Co-Investig.; 9/13-8/15, $408,546.
57. NIMH R34 MH099310, "2/2 Collaborative study: Testosterone augmentation in women," Co-Investig.; 9/13-8/16, $633,150.
| Year | Degree | Institution |
|---|---|---|
| 1978 | MD | University of Michigan |
| 1974 | BS | University of Michigan |
ACADEMIC APPOINTMENTS
Assistant Professor of Psychiatry, Yale University School of Medicine, New Haven, CT, 1983-1989.
Associate Unit Chief, Clinical Neuroscience Research Unit, Connecticut Mental Health Center, New Haven, CT, 1983-1988.
Co-Chief, Depression Clinic, Clinical Neuroscience Research Unit, Connecticut Mental Health Center, New Haven, CT, 1984-1987.
Chief, Inpatient Division, Clinical Neuroscience Research Unit, Connecticut Mental Health Center, New Haven, CT, 1984-1996.
Director, Clinical Neuroscience Research Unit, Connecticut Mental Health Center, New Haven, CT, 1988-1996.
Chief, Depression Clinic, Clinical Neuroscience Research Unit, Connecticut Mental Health Center, New Haven, CT, 1988-1995.
Associate Professor of Psychiatry, Yale University School of Medicine, New Haven, CT, 1989-1996.
Professor of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, RI, 1996-.
Director of Research, Butler Hospital, Providence, RI, 1996-.
Chief, Mood Disorders Program, Butler Hospital, Providence, RI, 1996-1997.
Medical Director, Butler Hospital, Providence, RI, 1997-8.
Clinical Director, Butler Hosp., Providence, RI, 1998-2012.
Interim Chief, General Adult Treatment Unit, Butler Hosp., Providence, RI, 2007.
Graduate Medical Education Designated Institutional Official, Butler Hosp., Providence, RI, 2009-2012.
Medical Director and Vice President of Medical Affairs, Butler Hosp., Providence, RI, 2012-2013.
Chief of Psychiatry, Women and Infants Hospital, Providence, RI, 2013-.
Senior Vice President and Chief Medical Officer, Butler Hosp., Providence, RI, 2013-2014.
Acting President and Chief Operating Officer, Butler Hosp., Providence, RI, 2014-2015.
President and Chief Operating Officer, Butler Hosp., Providence, RI, 2015-.
HOSPITAL APPOINTMENTS
Attending psychiatrist, Yale-New Haven Hospital, New Haven, CT, 1982-83; 1988-1996.
Attending psychiatrist, Connecticut Mental Health Center, New Haven, CT, 1983-1996.
Attending psychiatrist, Butler Hospital, Providence, RI, 1996-.
Attending psychiatrist, Kent Hospital, Warwick, RI, 1997-.
Consulting psychiatrist, Women and Infants Hospital, Providence, RI, 2013-.
| Medical License | Rhode Island | 1996- | |
| Diplomate | American Board of Psychiatry and Neurology, General psychiatry | 1983-2015 | |
| Medical License | Connecticut | 1980- | |
| Diplomate | National Board of Medical Examiners | 1979-2015 |
| Graduate Medical Education Designated Institutional Official. Butler Hospital, 2009-Present |
| Interim Chief. Butler Hospital, 2007- |
| Clinical Director. Butler Hospital, 1998-Present |
| Attending Psychiatrist. Kent Hospital, 1997-Present |
| Medical Director. Butler Hospital, 1997-1998 |
| Attending Psychiatrist. Butler Hospital, 1996-Present |
| Chief. Butler Hospital, 1996-1997 |
| Director of Research. Butler Hospital, 1996-Present |
| Director. Connecticut Mental Health Center, 1988-1996 |
| Chief. Connecticut Mental Health Center, 1988-1996 |
| Chief. Connecticut Mental Health Center, 1988-1995 |
| Attending Psychiatrist. Yale-New Haven Hospital, 1988-1996 |
| Co-Chief. Connecticut Mental Health Center, 1984-1987 |
| Attending Psychiatrist. Connecticut Mental Health Center, 1983-1996 |
| Associate Unit Chief. Connecticut Mental Health Center, 1983-1988 |
| Attending Psychiatrist. Yale-New Haven Hospital, 1982-1983 |
